|
|
 |
EDITORS-IN-CHIEF
|
| Stephen Maebius, Foley & Lardner | | Douglas Jamison, Harris & Harris Group |
| |
MANAGING EDITORS
|
John Miller, Arrowhead Research Corporation
Ruben Serrato, TEL Venture Capital
Mark Graffagnini, Wilson Sonsini
Andrew Baluch, Nanotechnology Law & Business
Drew Harris, Graves Dougherty Hearon & Moody
| |
Orion Steele, Nanotechnology Law & Business
William Pentland, Nanotechnology Law & Business |
| |
FOUNDING EDITOR
|
Elisabeth Lutanie, Computercraft Corporation
|
| |
ASSISTANT EDITORS
|
Stephen Chittenden, Michigan State Univ. Law
Derek Hecht, University of San Diego
Amber Hottes, Nanotechnology Law & Business
|
|
Tatiana Melnik, University of Michigan Law
|
| |
ASSOCIATE EDITORS
|
Lynn Bergeson, Bergeson & Campbell, P.C.
Diana Bowman, Monash University, Australia
Geert van Calster, K.U. Leuven and Oxford University; DLA Piper Solicitors
Don Featherstone, Sterne Kessler
Michael Gertner, Stanford University
Doron Goldstein, Dewey Ballantine
Kirk Hermann, Nanotechnology Law & Business
Dean Ho, Northwestern University
Timothy Hsieh, Min, Hsieh & Hack
Kelly Kordzik, Fish & Richardson
Griffith Kundahl, Nanobusiness Alliance
Lerwen Liu, Nanotechnology Research Institute
Patrick Lin, Nanoethics Group
Michele Mekel, Center on Nanotechnology and Society
|
|
John Monica, Porter Wright Morris & Arthur LLP
John Paul, Finnegan Henderson
Stuart Pulvirent, Think Equity Partners
Denis Rice, Howard Rice
Robert Shaddox, Winstead Sechrest
Sagiv Shiv, Merriman Curhan Ford
Rachael Simonoff Wexler, Goodwin Procter LLP
Chad Wieland, Buchanan Ingersoll
Bryan Wilson, Patent Trademark Office
Rich Wolf, Capital Group
|
| |
ADVISORY BOARD
|
Raj Bawa, Bawa Biotechnology Consulting & RPI
Kitu Bindra, Buchanan Ingersoll
Ronald Bleeker, Finnegan Henderson
Clinton Bybee, ARCH Venture Partners
Tom Cellucci, Department of Homeland Security
Ravi Chandra, John Hopkins
Nigel Cameron, Center for Policy on Emerging Technologies
Todd Dickinson, General Electric
Matthew Dixon, ip21 Ltd.
Peter Dobson, University of Oxford
Luca Escoffier, CBM scrl
Lynn Foster, BPT Pharmaceuticals, Inc
Ross Garsson, Fish & Richardson
Nathan Guisinger, NIST
Albert Halluin, Wilson Sonsini Goodrich & Rosati
Mark Hayman, Cooley Godward Kronish LLP
Michael Heintz, Porter Wright Morris & Arthur LLP
Glenn Killoren, Barnes & Thornburg LLP
Mark Lemley, Stanford Law School
Elizabeth F. Mason, Anderson & Kreiger LLP
Northon Melo, Think Equity Partners
Sonia E. Miller, S.E. Miller Law Firm
Chad Mirkin, Northwestern University
Mark Modzelewski, Nanodynamics
Shoichi Okuyama, Okuyama & Co.
|
|
Chinh H. Pham, Greenberg Traurig, LLP
Leon Radomsky, Foley & Lardner
Diego Rey, Cornell University
Glenn Reynolds, University of Tennessee
Mike Roco, National Science Foundation
Reed D. Rubinstein, Greenberg Traurig, LLP
Ottilia Saxl, Institute of Nanotechnology
Geoffrey Schmidt, Harvard University
Joop Schoonman, TU Delft
Purnesh Seegopaul, Pangaea Ventures
Michael Specht, Sterne Kessler
Donald Tomalia, Dendritic Nanotechnologies
Todd Vare, Barnes & Thornburg LLP
David Wallace, Chadbourne & Parke
Josh Wolfe, Lux Capital |
| |
|
|
